Results 231 to 240 of about 78,658 (276)

Targeting Txnip-mediated metabolic reprogramming has therapeutic potential for osteoarthritis. [PDF]

Cell Death Discov
Cao X, Yang X, Zhang P, Xu J, Zhao J, Yang E.   +5 more
europepmc   +1 more source

In search of real-world cerebroprotection: An institutional perspective and review of the literature. [PDF]

Interv Neuroradiol
Thompson LJ, Furst T, Whyte R, Kohli GS, Schartz DA, Bhalla T, Nguyen VN, Bender MT, Mattingly TK.   +8 more
europepmc   +1 more source

Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology. [PDF]

Europace
Merino JL, Tamargo J, Blomström-Lundqvist C, Boriani G, Crijns HJGM, Dobrev D, Goette A, Hohnloser SH, Naccarelli GV, Reiffel JA, Tfelt-Hansen J, Martínez-Cossiani M, Camm AJ, Almendral Garrote JM, Średniawa B, Kułakowski P, Savelieva I, Potpara T, Gorenek B, Zamorano JL.   +19 more
europepmc   +1 more source

Hallmarks of primary headache: part 3 - cluster headache. [PDF]

J Headache Pain
Coppola G, Arruda MA, Ashina M, Barloese M, Belin AC, Bottiroli S, Chowdhury D, De Icco R, Di Lorenzo C, Di Stefano G, Edvinsson JCA, Evers S, Ferraro S, Fronczek R, García-Azorín D, Goadsby PJ, Grazzi L, Holle D, Jansen JJ, Gil-Gouveia R, Lambru G, Lanteri-Minet M, Lisicki M, Mitsikostas DD, Monteith T, Montisano DA, Obermann M, Pan LH, Peng KP, Peres M, Petrušić I, Cecchini AP, Vila-Pueyo M, Raggi A, Rainero I, Sandrini G, Sebastianelli G, Takizawa T, Tanprawate S, Tassorelli C, Truini A, Valeriani M, Vuralli D, Waliszewska-Prosół M, Wang SJ, Wang Y, Wijeratne T, Martelletti P.   +47 more
europepmc   +1 more source

Antifungal exposure can enhance Candida glabrata pathogenesis

Ribeiro GF, Danecka W, Tomlinson L, Wallace EW, Childers DS.   +4 more
europepmc   +1 more source

Verapamil and its metabolite norverapamil inhibit the Mycobacterium tuberculosis MmpS5L5 efflux pump to potentiate the activity bedaquiline and other antitubercular drugs

Fountain AJ, Waller NJ, Cheung C, Jowsey W, Chrisp MT, Troll M, Edelstein PH, Cook GM, McNeil MB, Ramakrishnan L.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ionization and Surface Properties of Verapamil and Several Verapamil Analogues

Journal of Pharmaceutical Sciences, 1986
We have investigated the ionization and surface properties of verapamil (5-[(3,4-dimethoxyphenethyl)methylamino]-2-(3, 4-dimethoxyphenyl)-2-isopropylvaleronitrile, 1) and several verapamil analogues since these properties appear to be involved in the biologic activities of these compounds.
Gregory S. Retzinger, S.H. Lau, Louis Cohen, Ferenc J. Kezdy   +3 more
openaire   +3 more sources

Clinical Pharmacokinetics of Verapamil

Clinical Pharmacokinetics, 1984
Verapamil is widely used in the treatment of supraventricular tachyarrhythmias as well as for hypertension and control of symptoms in angina pectoris. Unlike other calcium antagonists, detailed pharmacokinetic data are available for verapamil. Plasma concentrations of verapamil appear to correlate with both electrophysiological and haemodynamic ...
Scott R. Hamann, Scott R. Hamann, Robert A. Blouin, Robert A. Blouin, R. G. McAllister, R. G. McAllister   +5 more
openaire   +3 more sources